Identification of Molecular Patterns of Anoikis and Epithelial-Mesenchymal Transition-Combined Index for Colorectal Cancer and the Regulatory Role of LTBP1 in Colorectal Cancer

Xiuyuan Zhang,Qizhen Ye,Yuwei Ding,Ning Zhu,Shanshan Weng,Jiaqi Chen,Caixia Dong,Ying Yuan
DOI: https://doi.org/10.21203/rs.3.rs-4938895/v1
2024-01-01
Abstract:Colorectal cancer (CRC) is the most common digestive tumor, and patients with advanced CRC have a very poor prognosis. Anoikis is a form of apoptosis induced by the loss of cell attachment or the interruption of adhesion-dependent signaling pathways and tumor cells can become resistant to anoikis when detached from the stroma. Anoikis resistance (AR) is a prerequisite for and an important indicator of the metastatic potential of tumor cells. While AR and epithelial mesenchymal transition (EMT) play important roles in the progression of CRC, the joint role of the two is not clear in CRC. In this study, based on anoikis and EMT-related genes, CRC patients were divided into two groups, AERG clusters A and B, by consensus clustering. Survival and enrichment analyses revealed that the cluster B group had a shorter survival and was more inclined to have AR and EMT characteristics. We established an AERG score based on a cluster of seven genes. Comprehensive analyses, including survival analysis, immune infiltration analysis, drug sensitivity analysis, and gene mutation analysis, indicated that the AERG score holds significant clinical relevance. The signature gene of AERG score, LTBP1, is highly expressed in CRC and is associated with poor prognosis. Subsequently, in vitro and in vivo experiments verified the biological function of LTBP1, and the knockdown of LTBP1 can inhibit CRC cell proliferation, migration, and apoptosis resistance. In addition, our findings suggest that LTBP1 could be instrumental in CRC, supporting its potential as a therapeutic target for CRC treatment.
What problem does this paper attempt to address?